These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 23052483

  • 1. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
    Guo XL, Li D, Sun K, Wang J, Liu Y, Song JR, Zhao QD, Zhang SS, Deng WJ, Zhao X, Wu MC, Wei LX.
    J Mol Med (Berl); 2013 Apr; 91(4):473-83. PubMed ID: 23052483
    [Abstract] [Full Text] [Related]

  • 2. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
    Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O'Dwyer PJ.
    Clin Cancer Res; 2013 Jun 01; 19(11):2995-3007. PubMed ID: 23461901
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N.
    Int J Cancer; 2012 Aug 01; 131(3):548-57. PubMed ID: 21858812
    [Abstract] [Full Text] [Related]

  • 4. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy.
    Wei PL, Huang CY, Chang YJ.
    PLoS One; 2019 Aug 01; 14(1):e0210513. PubMed ID: 30653551
    [Abstract] [Full Text] [Related]

  • 5. Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
    Xiong YQ, Sun HC, Zhu XD, Zhang W, Zhuang PY, Zhang JB, Xu HX, Kong LQ, Wu WZ, Qin LX, Tang ZY.
    J Cancer Res Clin Oncol; 2011 Mar 01; 137(3):505-12. PubMed ID: 20490863
    [Abstract] [Full Text] [Related]

  • 6. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
    Dong L, Luo L, Wang Z, Lian S, Wang M, Wu X, Fan J, Zeng Y, Li S, Lv S, Yang Y, Chen R, Shen E, Yang W, Li C, Wang K.
    Free Radic Biol Med; 2024 Aug 01; 220():111-124. PubMed ID: 38697493
    [Abstract] [Full Text] [Related]

  • 7. Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
    Huynh H, Chow PK, Palanisamy N, Salto-Tellez M, Goh BC, Lee CK, Somani A, Lee HS, Kalpana R, Yu K, Tan PH, Wu J, Soong R, Lee MH, Hor H, Soo KC, Toh HC, Tan P.
    J Hepatol; 2008 Jul 01; 49(1):52-60. PubMed ID: 18490075
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy.
    Guo XL, Hu F, Zhang SS, Zhao QD, Zong C, Ye F, Guo SW, Zhang JW, Li R, Wu MC, Wei LX.
    Cancer Lett; 2014 May 01; 346(2):278-84. PubMed ID: 24462821
    [Abstract] [Full Text] [Related]

  • 9. Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.
    Zhou F, Hu J, Shao JH, Zou SB, Shen SL, Luo ZQ.
    J Cancer Res Clin Oncol; 2012 Nov 01; 138(11):1879-90. PubMed ID: 22736027
    [Abstract] [Full Text] [Related]

  • 10. Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.
    Ong LC, Song IC, Jin Y, Kee IH, Siew E, Yu S, Thng CH, Huynh H, Chow PK.
    Mol Imaging Biol; 2009 Nov 01; 11(5):334-42. PubMed ID: 19330383
    [Abstract] [Full Text] [Related]

  • 11. Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma.
    Huynh H, Ngo VC, Choo SP, Poon D, Koong HN, Thng CH, Toh HC, Zheng L, Ong LC, Jin Y, Song IC, Chang AP, Ong HS, Chung AY, Chow PK, Soo KC.
    Curr Cancer Drug Targets; 2009 Sep 01; 9(6):738-47. PubMed ID: 19754358
    [Abstract] [Full Text] [Related]

  • 12. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 13. Combination of bevacizumab and acyclic retinoid inhibits the growth of hepatocellular carcinoma xenografts.
    Kubota M, Shimizu M, Baba A, Ohno T, Kochi T, Shirakami Y, Moriwaki H.
    J Nutr Sci Vitaminol (Tokyo); 2014 Oct 06; 60(5):357-62. PubMed ID: 25744425
    [Abstract] [Full Text] [Related]

  • 14. Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.
    Le TBU, Vu TC, Ho RZW, Prawira A, Wang L, Goh BC, Huynh H.
    Int J Mol Sci; 2020 Dec 10; 21(24):. PubMed ID: 33321903
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.
    Klose J, Stankov MV, Kleine M, Ramackers W, Panayotova-Dimitrova D, Jäger MD, Klempnauer J, Winkler M, Bektas H, Behrens GM, Vondran FW.
    PLoS One; 2014 Dec 10; 9(5):e95970. PubMed ID: 24816744
    [Abstract] [Full Text] [Related]

  • 16. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, Shi GM, Ke AW, Wang XY, Song K, Dai Z, Shen YH, Fan J.
    Clin Cancer Res; 2011 Oct 01; 17(19):6229-38. PubMed ID: 21825039
    [Abstract] [Full Text] [Related]

  • 17. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.
    BMC Cancer; 2012 May 04; 12():166. PubMed ID: 22559167
    [Abstract] [Full Text] [Related]

  • 18. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.
    Kim SM, Han JM, Le TT, Sohng JK, Jung HJ.
    Int J Mol Sci; 2020 Jun 05; 21(11):. PubMed ID: 32516967
    [Abstract] [Full Text] [Related]

  • 19. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway.
    He H, He M, Wang Y, Xiong H, Xiong Y, Shan M, Liu D, Guo Z, Kou Y, Zhang Y, Yang M, Lian J, Sun L, He F.
    Exp Cell Res; 2024 Jun 01; 439(1):114094. PubMed ID: 38750718
    [Abstract] [Full Text] [Related]

  • 20. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
    Zhu XD, Zhang JB, Fan PL, Xiong YQ, Zhuang PY, Zhang W, Xu HX, Gao DM, Kong LQ, Wang L, Wu WZ, Tang ZY, Ding H, Sun HC.
    BMC Cancer; 2011 Jan 20; 11():28. PubMed ID: 21251271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.